Key terms
About ATR
AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage. The company was founded in 1940 and is headquartered in Crystal Lake, IL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ATR news
Today
5:48am ET
AptarGroup’s Strong Q1 Performance and Robust Pharmaceutical Growth Justify Buy Rating
Mar 07
7:07am ET
AptarGroup price target raised to $160 from $157 at Wells Fargo
Feb 29
5:30am ET
Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX), Sarepta Therapeutics (SRPT) and AptarGroup (ATR)
Feb 13
7:20am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (ATR), Halozyme (HALO) and Bausch Health Companies (BHC)
Feb 12
6:09am ET
AptarGroup price target raised to $157 from $152 at Wells Fargo
Feb 12
5:55am ET
AptarGroup: Strong Buy on Pharma Growth and Operational Efficiency
Feb 11
11:55am ET
AptarGroup’s Strong Performance and Growth Prospects Merit a Buy Rating
Feb 10
1:02am ET
Bad News for AptarGroup, Inc. Stock: This New Risk Has Been Added
Feb 09
10:03am ET
Aptar Digital Health enters enterprise agreement with Biogen
Feb 08
5:07pm ET
AptarGroup sees Q1 EPS $1.10-$1.18, consensus $1.12
Feb 08
5:06pm ET
AptarGroup reports Q4 adjusted EPS $1.21, consensus $1.12
No recent press releases are available for ATR
ATR Financials
Key terms
Ad Feedback
ATR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ATR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
